Adaptin Bio (APTN) Assets Average (2023 - 2026)

Adaptin Bio has disclosed Assets Average across 4 years of filings, most recently posting $662638.0 for Q1 2026.

• Quarterly Assets Average fell 57.16% year-over-year to $662638.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $662638.0 (down 57.16% YoY) and the FY2025 annual result came in at $429287.0, up 258.04% from the prior year.
• Assets Average slipped to $662638.0 in Q1 2026, from $799316.5 in the prior quarter.
• Across five years, Assets Average topped out at $2.3 million in Q2 2025 and bottomed at $322.0 in Q3 2024.
• The 4-year median for Assets Average is $391253.2 (2024), against an average of $670934.0.
• Year-over-year, Assets Average jumped 643295.87% in 2025 and sank 57.16% in 2026.
• Adaptin Bio's Assets Average stood at $380.0 in 2023, then soared by 31444.34% to $119868.5 in 2024, then jumped by 566.83% to $799316.5 in 2025, then declined by 17.1% to $662638.0 in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $662638.0, $799316.5, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.